Table 4.
Persistent Normoglycemia | Baseline Hyperglycemia | 24-h Hyperglycemia | Persistent Hyperglycemia | |
---|---|---|---|---|
three-month poor outcome † | 1 | 1.20 (0.43–3.31) |
3.01 (0.75–12.70) |
4.91 (1.15–20.94) p = 0.03 |
No major neurological improvement at discharge † | 1 | 4.43 (1.57–12.53) p = 0.005 |
4.29 (1.01–12.53) p = 0.05 |
8.62 (2.01–36.99) p = 0.004 |
In-hospital mortality † | 1 | 0.25 (0.02–2.47) |
3.27 (0.57–18.64) |
2.80 (0.65–12.08) |
three-month mortality † | 1 | 0.49 (0.11–2.11) |
1.24 (0.26–5.97) |
1.81 (0.44–7.45) |
Presence of ICH ‡ | 1 | 0.93 (0.28–3.03) |
0.16 (0.01–1.84) |
7.15 (1.98–25.76) p = 0.003 |
Presence of SICH ‡ | 1 | 1.26 (0.29–5.52) |
1.27 (0.18–9.07) |
8.26 (1.95–35.01) p = 0.004 |
ICH: intracranial hemorrhage; SICH: symptomatic intracranial hemorrhage. † Adjusted for age, use of antidiabetic drugs, intravenous thrombolysis, baseline NIHSS score, pre-stroke mRS, time from symptom onset to treatment, and successful recanalization. ‡ Adjusted for age, use of antidiabetic drugs, intravenous thrombolysis, baseline NIHSS score, pre-stroke mRS, time from symptom onset to treatment, successful recanalization and systolic blood pressure > 180 mmHg.